Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Other solid neoplasm 1

Conditions

Testicular Germ Cell Tumor 1Prostatic Neoplasms 1Endodermal Sinus Tumor 1

Interventions

Docetaxel 205Prednisone 151enzalutamide 128Gemcitabine 123Radiotherapy 117Sunitinib 112Cisplatin 103Leuprolide 98pembrolizumab 96Abiraterone Acetate 94bicalutamide 87Nivolumab 85Goserelin 83Sorafenib 80Paclitaxel 79Carboplatin 77Everolimus 72Bevacizumab 71Magnetic Resonance Spectroscopy 66acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 61pazopanib 56radium Ra 223 dichloride 50Ipilimumab 49Zoledronic Acid 47Cyclophosphamide 44Radiosurgery 43Filgrastim 42abiraterone 41gallium 68 PSMA-11 40Surveys and Questionnaires 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × sabarubicin × Genitourinary × Clear all
NCT00027781 2012-07-24

MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
37 enrolled
Genitourinary

Prostatic Neoplasms

NCT00003982 2012-07-11

MEN-10755 in Treating Patients With Solid Tumors

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
30 enrolled
Genitourinary

Testicular Germ Cell Tumor, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡